Effect of tacrolimus on hemodynamics and absorption of experimental small intestinal transplants

Transplantation

Volumn 61, Issue 10, 1996, Pages 1447-1450

  Sun, Shuching ^a   Katz, Steven M ^a   Schechner, Richard S ^a   Tellis, Vivian A ^a   Greenstein, Stuart M ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TACROLIMUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; GRAFT REJECTION; GRAFT SURVIVAL; HEMODYNAMICS; INTESTINE ABSORPTION; INTESTINE BLOOD FLOW; INTESTINE GRAFT; NEPHROTOXICITY; NONHUMAN; PERFUSION PRESSURE; PRIORITY JOURNAL; RAT; VASCULAR RESISTANCE;

ANIMALS; HEMODYNAMIC PROCESSES; IMMUNOSUPPRESSIVE AGENTS; INTESTINAL ABSORPTION; INTESTINE, SMALL; MALTOSE; RATS; RATS, INBRED LEW; REGIONAL BLOOD FLOW; TACROLIMUS; VASCULAR RESISTANCE;

EID: 0029900419     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199605270-00005     Document Type: Article

References (36)

1. Powell-Jackson PR, Youn B, Calne RY. Nephrotoxicity of parenterally-administered cyclosporine after orthotopic liver transplantation. Transplantation 1983; 36: 505.
2. Klintmalm GBG, Iwatsuki S, Starzl TE. Cyclosporine A hepatic toxicity in 66 renal allograft recipients. Transplantation 1981; 32: 488.
3. Calne RY, White DG, Evans DB, et al. Cyclosporine A in cadaveric organ transplantation. Br Med J 1981; 282: 934.
4. Crane PW, Clark C, Sowter C, et al. Cyclosporine toxicity in the small intestine. Transplant Proc 1990; 22: 2432.
5. Greenstein SM, Sun SC, Schechner RS, et al. Prolonged use of cyclosporine produces reversible hemodynamic and absorptive alteration in the transplanted rat small intestine. J Surg Res 1994; 56: 518.
6. Kort WJ, Westbroeck DL, MacDicken I, Lameizer LDF. Orthotopic total small bowel transplantation in the rat. Eur Surg Res 1973; 5: 81.
7. Billiar TR, Garberoglio C, Schraut WH. Maltose absorption as an indicator of small intestinal allograft rejection. J Surg Res 1984; 37: 75.
8. Norlen K, Rentzhog L, Wikstrom S. Microsphere measurement of regional intestinal blood supply and cardiac output in the rat. Upsala J Med Sci 1978; 83: 163.
9. Chung RS, Safaie-Shirazi S. Effect of acidification on duodenal mucosal blood flow. Surg Forum 1979; 30: 345.
10. Tocci MJ, Maktovich DA, Collier KA, et al. The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes. J Immunol 1989; 143: 718.
11. Tanaka H, Kuroda A, Marusawa H, et al. Structure of FK506, a novel immunosuppressant isolated from streptomyces. J Am Chem Soc 1987; 108: 5031.
12. Petcher TJ, Weber HP, Ruegger A. Crystal and molecular structure of an iododerivative of the cyclic undecapeptide cyclosporine A. Helv Chim Acta 1976; 59: 1480.
13. Ishibashi M. Japanese study of FK506 in kidney transplantation: results of early phase II study. Transplant Proc 1991; 23: 3071.
14. Fung JJ, Alessiani M, Abu-Elmagd K, Todo S, et al. Adverse effects associated with the use of FK506. Transplant Proc 1991; 23: 3105.
15. Bougneres PF, Carel JC, Castano L, et al. Factors associated with early remission of type I diabetes in children treated with cyclosporine. N Engl J Med 1988; 318: 663.
16. Langrehr JM, Markus PM, Lee TK, et al. Lethal graft-vs-host disease after cyclosporine therapy in recipients of sensitized small bowel allografts. Transplant Proc 1992; 24: 1138.
17. Santiago SF, Fukuzawa M, Azuma T, Okada A. Effect of short-term immunosuppressive therapy with FK506 or CyA on the donor in small intestine allotransplantation in rats. Transplant Proc 1992; 24: 1189.
18. Todo S, Tzakis A, Reyes K, et al. Intestinal transplantation at the University of Pittsburgh. Transplant Proc 1994; 26: 1409.
19. Hoffman A, Makowku L, Barnni B, et al. The use of FK506 for allotransplantation: inhibition of acute rejection and prevention of fatal GVHD. Transplantation 1990; 49: 483.
20. Santiago SF, Fukuzawa M, Azuma T, Okada A. Effect of donor pretreatment with FK506 upon small intestine allotransplantation in rats. Transplant Proc 1991; 23: 3243.
21. Nalesnik MA, Lai HS, Murase N, et al. The effect of FK506 and CsA on the Lewis rat renal ischemia model. Transplant Proc 1990; 22(suppl 1): 87.
22. Shapiro R, Jordan M, Fung J, et al. Kidney transplantation under FK506 immunosuppression. Transplant Proc 1991; 23: 920.
23. McCauley J, Fung J, Jain A, et al. The effect of FK506 on renal function after liver transplantation. Transplant Proc 1990; 22(suppl 1): 17.
24. Crane PW, Lear PA, Sowter C, et al. Early microvascular changes in small intestinal allografts. Transplant Proc 1989; 21: 2906.
25. Nossal GJV. Summary of the First International FK506 Congress: perspectives and prospects. Transplant Proc 1991; 23: 3371.
26. Ueda D, Tajima A, Ohtawara Y, et al. Influence of FK506 on renal blood flow. Transplant Proc 1991; 23: 3121.
27. Kumano K, Wang G, Endo T, Kuwao S. FK506 induced nephrotoxicity in rats. Transplant Proc 1991; 23: 512.
28. Todo S, Ueda Y, Demetris JA, et al. Immunosuppression of canine, monkey, and baboon allografts by FK506: with special reference to synergism with other drugs and to tolerance induction. Surgery 1988; 104: 239.
29. Collier DSJ, Calne R, Thiru S, et al. FK506 in experimental renal allografts in dogs and primates. Transplant Proc 1988; 20(suppl 1): 226.
30. Demetris AJ, Fung JJ, Todo S, et al. Pathologic observations in human allograft recipients treated with FK506. Transplant Proc 1990; 22(suppl 1): 25.
31. Ventkataramanan R, Jain A, Cadoff E, et al. Pharmacokinetics of FK506: preclinical and clinical studies. Transplant Proc 1990; 22(suppl 1): 52.
32. Harding MW, Galat A, Uehling DE, Schreiber SL. A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase. Nature 1989; 341: 758.
33. Montabarrik A, Ishibashi M, Fukuraga M, et al. FK506-induced kidney tubular injury. Transplantation 1992; 54: 1041.
34. Yanagizawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411.
35. Kon V, Suguira M, Inagami T, et al. Role of endothelin in cyclosporine-induced glomerular dysfunction. Kidney Int 1990; 37: 1487.
36. Benigni A, Morigi M, Perico N, et al. The acute effect of FK506 and cyclosporine on endothelial cell function and renal vascular resistance. Transplantation 1992; 54: 775.